Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®

An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immunogenicity and safety of the Southern Hemisphere 2015...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathilde Latreille-Barbier (Author), Regine Rouzier (Author), Beatrice Astruc (Author), Nathalie Lavis (Author), Yves Donazzolo (Author)
Format: Book
Published: Taylor & Francis Group, 2017-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available